Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis
- 1 January 2005
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 252 (1), 8-13
- https://doi.org/10.1007/s00415-005-0589-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1aDrug Safety, 2003
- Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN-β Preparations Used in the Treatment of Relapsing-Remitting Multiple SclerosisJournal of Interferon & Cytokine Research, 2002
- Randomized, comparative study of interferon β-1a treatment regimens in MSNeurology, 2002
- A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MSNeurology, 2002
- PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MSNeurology, 2001
- Pharmacodynamic Comparison of Single Doses of IFN-beta 1a and IFN-beta 1b in Healthy VolunteersJournal of Interferon & Cytokine Research, 1999
- Evidence of interferon β-1a dose response in relapsing-remitting MSNeurology, 1999
- Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markersJournal of Neuroimmunology, 1999
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995